Eric Yang,
Quark Biosciences
Dr. Eric Yang is the Director of Application Development at Quark Biosciences, a Xinzhu-based biotechnology firm which develops proprietary qPCR array technology as well as clinical diagnostic products. Dr. Yang currently spearheads several major projects at the company, including the development of non-invasive cancer diagnostic tests using blood-based microRNAs. At present, his effort has led to a number of collaborations with prominent Taiwanese hospitals and key opinion leaders. Dr. Yang grew up in Taiwan and left to attend college at the University of California, Los Angeles (UCLA). After receiving his bachelor’s degree in Biochemistry, he joined the laboratory of Guillaume Chanfreau at UCLA to further his studies in Molecular Biology. His doctoral thesis focused on deciphering the biogenesis of essential non-coding RNAs responsible for the modifications of ribosomal RNAs. His research effort has led to several grant approvals and awards. Upon receiving his Ph.D., Dr. Yang continued his research in long non-coding RNAs as a Howard Hughes Medical Institute Scholar at Harvard Medical School. There, he co-authored a number of key papers and a major review on the roles of non-coding RNAs.
|
|
|
